title: Is there a standard for the palliative treatment of melanoma?
authors.affiliation: Skin Cancer Unit of the German Cancer Research Center at the Department of Dermatology, University Hospital Mannheim. d.schadendorf@dkfz.de
authors.forename: D
authors.initials: D
authors.lastname: Schadendorf
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003606:Dacarbazine / Q000008:administration & dosage; D019317:Evidence-Based Medicine; D006801:Humans; D007372:Interferons / Q000008:administration & dosage; D007376:Interleukin-2 / Q000008:administration & dosage; D008545:Melanoma / Q000188:drug therapy*; D010166:Palliative Care / Q000592:standards*; D016032:Randomized Controlled Trials as Topic; D012878:Skin Neoplasms / Q000188:drug therapy*; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D007376:Interleukin-2; D003606:Dacarbazine; D007372:Interferons